Paper23909008
Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.
Wkly Epidemiol Rec, 2013. Cited by 118 papers, by iCite.
Cite this record
ConductScience Library. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013. Papers, record 23909008. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23909008
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mass Vaccination | Major topic |
| Yellow Fever | Major topic |
| Yellow Fever Vaccine | Major topic |
| Cost-Benefit Analysis | |
| Endemic Diseases | |
| Humans | |
| Immunity | |
| Yellow fever virus |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05332197 | Booster Vaccine for Yellow Fever | Background | ClinicalTrials.gov | |
| NCT05644145 | Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina | Background | ClinicalTrials.gov |
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42856775 | Immunological Correlate of Protection by PHV02 Live, Attenuated Recombinant VSV Vaccine Against Nipah Virus Disease Using an Improved Neutralizing Antibody Method, with Considerations for Future Research. | Res Sq | 2026 | https://conductscience.org/library/papers/42856775 | PubMed |
| 42797577 | Adverse Events Following Yellow Fever Vaccination in Older Adults in Colombia, 2024-2025: A National Pharmacovigilance Analysis. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797577 | PubMed |
| 42447166 | Immunoprevention and immunomodulation of yellow fever: A scoping review of global and Latin American evidence. | PLoS One | 2026 | https://conductscience.org/library/papers/42447166 | PubMed |
| 40872893 | Bridging Gaps in Vaccine Access and Equity: A Middle Eastern Perspective. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40872893 | PubMed |
| 40733652 | A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40733652 | PubMed |
| 40432061 | From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40432061 | PubMed |
| 40333313 | Global Status of Adult Immunization Post COVID-19 Pandemic. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40333313 | PubMed |
| 40333208 | Safety and Efficacy of Vaccination During Lactation: A Comprehensive Review of Vaccines for Maternal and Infant Health Utilizing a Large Language Model Citation Screening System. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40333208 | PubMed |
| 40132321 | Identification of potential vaccines for use with microarray patches in low- and middle-income countries: An assessment from the Vaccine Innovation Prioritisation Strategy Alliance. | Vaccine | 2025 | https://conductscience.org/library/papers/40132321 | PubMed |
| 39935766 | Booster Vaccination against Yellow Fever in Gambian children-(BoVY) -a Phase 3 clinical trial to establish safety and immunogenicity of repeated YF vaccination in healthy Gambian children of different ages. | Wellcome Open Res | 2024 | https://conductscience.org/library/papers/39935766 | PubMed |
| 39424573 | The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial. | Lancet Glob Health | 2024 | https://conductscience.org/library/papers/39424573 | PubMed |
| 38735993 | Advancing molecular modeling and reverse vaccinology in broad-spectrum yellow fever virus vaccine development. | Sci Rep | 2024 | https://conductscience.org/library/papers/38735993 | PubMed |
| 38567951 | Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination. | J Virol | 2024 | https://conductscience.org/library/papers/38567951 | PubMed |
| 38155740 | Serological investigation of vaccine-induced antibodies for measles, rubella, and yellow fever viruses in children vertically exposed to Zika virus or with down syndrome. | Front Pediatr | 2023 | https://conductscience.org/library/papers/38155740 | PubMed |
| 38098643 | Are the first 1,000 days of life a neglected vital period to prevent the impact on maternal and infant morbimortality of infectious diseases in Latin America? Proceedings of a workshop of experts from the Latin American Pediatric Infectious Diseases Society, SLIPE. | Front Pediatr | 2023 | https://conductscience.org/library/papers/38098643 | PubMed |
| 37900033 | Mitigating the effects of climate change on human health with vaccines and vaccinations. | Front Public Health | 2023 | https://conductscience.org/library/papers/37900033 | PubMed |
| 37770632 | Immunological factors linked to geographical variation in vaccine responses. | Nat Rev Immunol | 2024 | https://conductscience.org/library/papers/37770632 | PubMed |
| 37433816 | YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/37433816 | PubMed |
| 37127045 | Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial. | Lancet Infect Dis | 2023 | https://conductscience.org/library/papers/37127045 | PubMed |
| 37000007 | Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA. | J Travel Med | 2023 | https://conductscience.org/library/papers/37000007 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23909008
GET https://conductscience.org/api/papers/v1/23909008/cited_by?page=2